![Thomas Folinsbee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Folinsbee
Directeur/Bestuurslid bij
CASI PHARMACEUTICALS, INC.
Vermogen: - $ op 31-03-2026
Profiel
Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2026 | 0 ( -.--% ) | - $ | 31-03-2026 |
Actieve functies van Thomas Folinsbee
| Bedrijven | Functie | Begin |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 21-03-2023 |
Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | 01-01-2019 |
Eerdere bekende functies van Thomas Folinsbee
| Bedrijven | Functie | Einde |
|---|---|---|
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Directeur/Bestuurslid | 01-01-2019 |
| 3SBIO INC. | Corporate Officer/Principal | 01-01-2019 |
Hisanaga Seisakusho Co. Ltd. | Directeur/Bestuurslid | 01-01-2016 |
| SUMT HEAL | Directeur/Bestuurslid | - |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Directeur/Bestuurslid | - |
Opleiding van Thomas Folinsbee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
89
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hisanaga Seisakusho Co. Ltd. | |
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
Summit Healthcare Acquisition Corp.
 Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Alebund Pharmaceuticals Ltd. | |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
